Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line

NASHVILLE, Tenn., Dec. 2, 2019 -- (Healthcare Sales & Marketing Network) -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) ... Biopharmaceuticals, FDA Cumberland Pharmaceuticals, RediTrex, methotrexate, arthritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news